Evaluation of the Auryzon™ EAR 2.0 System in Ear Reconstruction
Part of paid clinical trials in Orlando, Florida.
- Sponsor
- Nemours Children's Clinic
- Study ID
- NCT07154667
- Status
- Recruiting
Conditions
- Ear Cartilage
- Ear Deformities, Acquired
- Ear Deformity External
- Ear Malformation
- Microtia
- Microtia, Congenital
- Microtia-Anotia
Eligibility Criteria
- Sex
- ALL
- Age
- 5 Years - 20 Years
- Healthy Volunteers
- Not accepted
Interventions
- Use of AuryzoN™ EAR 2.0 device — PROCEDUREAuryzoN™ EAR 2.0 is an investigational non-significant risk device developed to improve cartilage construct shape and stability prior to use in ear reconstructive surgery.
- Hand carving — PROCEDUREStandard hand carving using standard surgical blades will be performed in this intervention arm of the study.
Study Details
This study aims to improve surgical outcomes for children and young adults with ear differences severe secondary to congenital conditions (like microtia, a condition where the ear is underdeveloped), trauma (such as dog bites), or surgical resections secondary to skin cancer. The investigators have developed a novel medical device to shape cartilage into pre-determined shapes that, once assembled, assists the surgeon in creating an anatomically accurate cartilaginous ear framework, reduce surgery time, and minimize wire need. Other factors that might affect the quality of surgical outcomes will be examined in clinical trial participants.
Key Dates
- Start date
- Oct 1, 2025
- Status verified
- Dec 2025
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: AuryzoN™ EAR 2.0 armParticipants in the AuryzoN™ EAR 2.0 arm will receive ear reconstruction surgery using the AuryzoN™ EAR 2.0 device
- Active Comparator: Hand CarvedParticipants in this arm will receive ear reconstruction surgery using the hand carved technique
Primary Outcome Measure
Evaluate the results of patient and parent satisfaction with the constructed ear's shape and appearance and compare the results between the hand-carved cohort and the AuryzoN™ EAR 2.0 cohort using a four-question survey. [ Time Frame: From the beginning of the study to the end at 5 years ]
Central Contacts
- Heaven Sippio - Executive Assistant407-650-7358
- Ishpriya Sharma - Research Project Specialist, PhD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Nemours Children's Hospital, Florida | Orlando | Florida | 32827 | Angelo A Leto Barone, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Orlando, FL
Related Studies
- Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCTPHASE2 · Recruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- InterNatIonal CHildhood Leukemia Microbiome/MEtabolome CohortRecruiting · Columbia University · New York, New York